Oseltamivir-resistant 2009–2010 pandemic influenza A (H1N1) in an immunocompromised patient
Open Access
- 1 October 2010
- journal article
- case report
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 16 (10) , 1576-1578
- https://doi.org/10.1111/j.1469-0691.2010.03212.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- H1N1 novel influenza A in pregnant and immunocompromised patientsCritical Care Medicine, 2010
- Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 InfluenzaNew England Journal of Medicine, 2010
- A Community Cluster of Oseltamivir-Resistant Cases of 2009 H1N1 InfluenzaNew England Journal of Medicine, 2010
- Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable populationInternational Journal of Hematology, 2009
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisBMJ, 2009
- Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, ChinaEmerging Infectious Diseases, 2009
- Molecular mechanisms of influenza virus resistance to neuraminidase inhibitorsVirus Research, 2004
- Prolonged Shedding of Multidrug-Resistant Influenza A Virus in an Immunocompromised PatientNew England Journal of Medicine, 2003
- The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivoAntiviral Research, 2002
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001